Works matching National Cancer Institute (U.S.)


Results: 5000
    1
    2
    3
    4
    5
    6

    Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

    Published in:
    2016
    By:
    • Bennett, Antonia V.;
    • Dueck, Amylou C.;
    • Mitchell, Sandra A.;
    • Mendoza, Tito R.;
    • Reeve, Bryce B.;
    • Atkinson, Thomas M.;
    • Castro, Kathleen M.;
    • Denicoff, Andrea;
    • Rogak, Lauren J.;
    • Harness, Jay K.;
    • Bearden, James D.;
    • Bryant, Donna;
    • Siegel, Robert D.;
    • Schrag, Deborah;
    • Basch, Ethan;
    • National Cancer Institute PRO-CTCAE Study Group
    Publication type:
    journal article
    7
    8
    9
    10
    11
    14
    15
    16
    18
    19
    20
    21

    MDM2 as a predictor of prostate carcinoma outcomeThe contents of the current article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or the U.S. Department of Defense.: An analysis of Radiation Therapy Oncology Group protocol 8610

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 5, p. 962
    By:
    • Li‐Yan Khor;
    • Michelle DeSilvio;
    • Tahseen Al‐Saleem;
    • M. Elizabeth Hammond;
    • David J. Grignon;
    • William Sause;
    • Michael Pilepich;
    • Paul Okunieff;
    • Howard Sandler;
    • Alan Pollack
    Publication type:
    Article
    22

    Heterogeneity of risk for melanoma and pancreatic and digestive malignanciesThis article is a U.S. Government work and, as such, is in the public domain in the United States of America.The opinions expressed herein do not necessarily reflect the views of the National Cancer Institute or the U.S. Government.: A melanoma casecontrol study

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 12, p. 2809, doi. 10.1002/cncr.20669
    By:
    • Joni L. Rutter;
    • Christina M. Bromley;
    • Alisa M. Goldstein;
    • David E. Elder;
    • Elizabeth A. Holly;
    • DuPont Guerry;
    • Patricia Hartge;
    • Jeffery P. Struewing;
    • David Hogg;
    • Allan Halpern;
    • Richard W. Sagebiel;
    • Margaret A. Tucker
    Publication type:
    Article
    23
    25
    29

    Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma (The views expressed herein do not necessarily reflect the views of the National Cancer Institute or the U.S. Government.).

    Published in:
    Cancer (0008543X), 2004, v. 100, n. 7, p. 1438
    By:
    • David A. Rizzieri;
    • Jeffrey L. Johnson;
    • Donna Niedzwiecki;
    • Edward J. Lee;
    • James W. Vardiman;
    • Bayard L. Powell;
    • Maurice Barcos;
    • Clara D. Bloomfield;
    • Charles A. Schiffer;
    • Bruce A. Peterson;
    • George P. Canellos;
    • Richard A. Larson
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50